BKK:KLINIQ Statistics
Total Valuation
BKK:KLINIQ has a market cap or net worth of THB 7.70 billion. The enterprise value is 7.61 billion.
Important Dates
The next estimated earnings date is Friday, November 20, 2026.
| Earnings Date | Nov 20, 2026 |
| Ex-Dividend Date | Aug 27, 2026 |
Share Statistics
BKK:KLINIQ has 220.00 million shares outstanding. The number of shares has increased by 0.29% in one year.
| Current Share Class | 220.00M |
| Shares Outstanding | 220.00M |
| Shares Change (YoY) | +0.29% |
| Shares Change (QoQ) | -0.56% |
| Owned by Insiders (%) | 65.89% |
| Owned by Institutions (%) | 0.74% |
| Float | 75.05M |
Valuation Ratios
The trailing PE ratio is 15.82 and the forward PE ratio is 13.76. BKK:KLINIQ's PEG ratio is 0.64.
| PE Ratio | 15.82 |
| Forward PE | 13.76 |
| PS Ratio | 1.72 |
| PB Ratio | 4.30 |
| P/TBV Ratio | 4.31 |
| P/FCF Ratio | 12.06 |
| P/OCF Ratio | 7.77 |
| PEG Ratio | 0.64 |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 7.47, with an EV/FCF ratio of 11.91.
| EV / Earnings | 15.59 |
| EV / Sales | 1.70 |
| EV / EBITDA | 7.47 |
| EV / EBIT | 11.81 |
| EV / FCF | 11.91 |
Financial Position
The company has a current ratio of 1.11, with a Debt / Equity ratio of 0.38.
| Current Ratio | 1.11 |
| Quick Ratio | 0.68 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | 0.68 |
| Debt / FCF | 1.08 |
| Interest Coverage | 23.27 |
Financial Efficiency
Return on equity (ROE) is 28.15% and return on invested capital (ROIC) is 29.87%.
| Return on Equity (ROE) | 28.15% |
| Return on Assets (ROA) | 12.19% |
| Return on Invested Capital (ROIC) | 29.87% |
| Return on Capital Employed (ROCE) | 27.72% |
| Weighted Average Cost of Capital (WACC) | 5.09% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 526 |
| Asset Turnover | 1.36 |
| Inventory Turnover | 6.06 |
Taxes
In the past 12 months, BKK:KLINIQ has paid 134.21 million in taxes.
| Income Tax | 134.21M |
| Effective Tax Rate | 21.55% |
Stock Price Statistics
The stock price has increased by +69.08% in the last 52 weeks. The beta is 0.18, so BKK:KLINIQ's price volatility has been lower than the market average.
| Beta (5Y) | 0.18 |
| 52-Week Price Change | +69.08% |
| 50-Day Moving Average | 30.63 |
| 200-Day Moving Average | 27.28 |
| Relative Strength Index (RSI) | 62.92 |
| Average Volume (20 Days) | 470,911 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BKK:KLINIQ had revenue of THB 4.48 billion and earned 487.94 million in profits. Earnings per share was 2.21.
| Revenue | 4.48B |
| Gross Profit | 2.31B |
| Operating Income | 644.13M |
| Pretax Income | 622.76M |
| Net Income | 487.94M |
| EBITDA | 870.54M |
| EBIT | 644.13M |
| Earnings Per Share (EPS) | 2.21 |
Full Income Statement Balance Sheet
The company has 790.55 million in cash and 688.54 million in debt, with a net cash position of 102.02 million or 0.46 per share.
| Cash & Cash Equivalents | 790.55M |
| Total Debt | 688.54M |
| Net Cash | 102.02M |
| Net Cash Per Share | 0.46 |
| Equity (Book Value) | 1.80B |
| Book Value Per Share | 8.14 |
| Working Capital | 128.38M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 991.45 million and capital expenditures -352.80 million, giving a free cash flow of 638.66 million.
| Operating Cash Flow | 991.45M |
| Capital Expenditures | -352.80M |
| Depreciation & Amortization | 226.41M |
| Net Borrowing | -164.53M |
| Free Cash Flow | 638.66M |
| FCF Per Share | 2.90 |
Full Cash Flow Statement Margins
Gross margin is 51.56%, with operating and profit margins of 14.37% and 10.88%.
| Gross Margin | 51.56% |
| Operating Margin | 14.37% |
| Pretax Margin | 13.89% |
| Profit Margin | 10.88% |
| EBITDA Margin | 19.42% |
| EBIT Margin | 14.37% |
| FCF Margin | 14.25% |
Dividends & Yields
This stock pays an annual dividend of 1.45, which amounts to a dividend yield of 4.14%.
| Dividend Per Share | 1.45 |
| Dividend Yield | 4.14% |
| Dividend Growth (YoY) | 12.41% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 73.49% |
| FCF Payout Ratio | 56.15% |
| Buyback Yield | -0.29% |
| Shareholder Yield | 3.86% |
| Earnings Yield | 6.32% |
| FCF Yield | 8.29% |
Dividend Details Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside | |
Analyst Forecast
The average price target for BKK:KLINIQ is 40.19, which is 14.83% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 40.19 |
| Price Target Difference | 14.83% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 17.55% |
| EPS Growth Forecast (3Y) | 19.77% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |